Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 7/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.51 |
| ▸ | METAP2 | P50579 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19204432 | 0.82 | GAA (0.65) | GAASMN1; SMN2MAPTLMNAPOLB | |
| SCHEMBL19204430 | 0.82 | GAA (0.65) | GAASMN1; SMN2MAPTLMNAPOLB | |
| SCHEMBL19204433 | 0.82 | GAA (0.65) | GAASMN1; SMN2MAPTLMNAPOLB | |
| SCHEMBL22017807 | 0.82 | GAA (0.65) | GAASMN1; SMN2MAPTLMNAPOLB | |
| SCHEMBL21160883 | 0.80 | GAA (0.67) | GAASMN1; SMN2MAPTLMNAPOLB | |
| SCHEMBL19204353 | 0.80 | GAA (0.67) | GAASMN1; SMN2MAPTLMNAPOLB | |
| SCHEMBL19204427 | 0.78 | SMN1; SMN2 (0.68) | GAASMN1; SMN2METAP2HPGDMAPT | |
| SCHEMBL7431354 | 0.77 | HPGD (0.69) | GAASMN1; SMN2METAP2HPGDLMNA | |
| SCHEMBL20268099 | 0.75 | HPGD (0.66) | GAASMN1; SMN2HPGDMAPTLMNA | |
| SCHEMBL2257991 | 0.72 | GAA (0.70) | GAASMN1; SMN2HPGDMAPTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10662147-B2 | Phenylhydrazine/anhydride adducts and anaerobic curable compositions using same | Henkel IP & Holding GmbH (DE) | 2020-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10662147-B2 | Phenylhydrazine/anhydride adducts and anaerobic curable compositions using same | AHCY, BAP1, GLO1 | GAA 2944/4885SMN1; SMN2 2004/4885METAP2 1351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.